IATA Awards CEIV Pharma Certificate to FedEx Global Healthcare

Key Highlights:

• FedEx receives CEIV Pharma Corporate Certification from IATA for its global healthcare network.
• Over 90% of FedEx’s global healthcare volume now moves through certified facilities.
• Certification affirms FedEx’s compliance with stringent pharmaceutical logistics standards.

FedEx Corp. (NYSE: FDX) has gained recognition from the International Air Transport Association (IATA) through its CEIV Pharma Corporate Certification which values its strong commitment to handling pharmaceuticals well across the world.

Announced during the 34th CNS Partnership Conference, FedEx received this certification in recognition of the effectiveness of its quality management at its global hubs and ramps, showing it can meet strict guidelines of the pharmaceutical industry.

Also read: Personalized Medicine: Get Tailored Treatment Plans for You Now

According to Nick Gennari, President of Global Healthcare and Commercial Sales at FedEx, “This certification illustrates FedEx’s unwavering dedication to excellence in pharmaceutical logistics. This pioneering, network-wide approach to quality showcases our commitment to complying with the highest standards in the industry for the transportation and handling of global pharmaceutical products.”

 IATA’s CEIV Pharma gives pharma products a good reputation because it ensures they are safely, properly and temperature-controlled during air transport. The IATA’s Senior Vice President of Commercial Products and Services, Frederic Leger, commends FedEx for getting certified for more capabilities, since keeping all global standards steady is key to the proper handling of time-sensitive medical goods.

This achievement proves that FedEx leads in the pharmaceutical logistics sector and continues to back the complex needs of the healthcare industry worldwide.